FindTrial
Sign In

Morphological Patterns of Hospital Acquired Pneumonia and Associated Carbapenem Resistance in Bacterial Pathogens

Microbiological Profile of Hospital Acquired Pneumonia with Detection of Carbapenem Resistance in Bacterial Isolates in a Tertiary Care Hospital - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/100303
Enrollment
210
Registered
2026-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J189- Pneumonia, unspecified organism

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr Dhivya Rajendran
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient diagnosed with Hospital Acquired Pneumonia after 48 hours of Hospital Admission. 2.Patient with clinical signs of Hospital Acquired Pneumonia (Fever, cough and Purulent sputum) who was admitted to the intensive care unit or ward.

Exclusion criteria

Exclusion criteria: Patient with Community Acquired Pneumonia.

Design outcomes

Primary

MeasureTime frame
To isolate and identify pathogen causing Hospital Acquired Pneumonia and aid for effective empiric treatment guidelines.Timepoint: 2 years—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Dhivya Rajendran

Vinayaka Missions Kirupananda Variyar Medical College and Hospitals, Salem.

drmathavimicro@gmail.com9600251333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026